Salute e Benessere

Zero Candida Applies to List its Shares on the TSX Venture Exchange

Immediately following the completion of the Acquisition, the following persons were appointed as directors of the Company: Immediately following the completion of the Acquisition, the following persons were appointed as directors of the Company: Eli Ben-HarooshAsher Holzer Orit Berger Christina Cameron Also, immediately following the completion of the Acquisition, the following persons were appointed as officers of the Company: Eli Ben-Haroosh, Chief Executive OfficerSophya...
PR Newswire
18/11/2024

Zero Candida Applies to List its Shares on the TSX Venture Exchange

Immediately following the completion of the Acquisition, the following persons were appointed as directors of the Company: Immediately following the completion of the Acquisition, the following persons were appointed as directors of the Company: Eli Ben-HarooshAsher Holzer Orit Berger Christina Cameron Also, immediately following the completion of the Acquisition, the following persons were appointed as officers of the Company: Eli Ben-Haroosh, Chief Executive OfficerSophya...
PR Newswire
18/11/2024

Novonesis will host an educational conference call on Energy on December 18

Novonesis will host a spotlight educational session on our Energy activities which is part of Planetary Health Biosolutions. We will share insights about the industry, its development, and Novonesis' integral part of the industry's value chain. The session will be hosted as a conference call on December 18 at 15:00 CET.To join the live webcast, please clickhere.To register and receive access details for the conference call, please clickhere. Attachment 2024_Spotlight_Energy ...
Nasdaq GlobeNewswire
18/11/2024

Zimmer Biomet Announces CE Mark Certification for Persona® Revision Knee System

The Persona Revision Knee offers a personalized fit and optimized function for patients undergoing revision knee surgery. The modular system allows for intraoperative flexibility, so surgeons can address a wide range of complex cases with precision and ease. The system features Zimmer Biomet's proprietary Trabecular Metal™ Technology, which promotes long-term bone in-growth and improves implant fixation.1 2 3 The Persona Revision Knee offers a personalized fit and optimized function for...
PR Newswire
18/11/2024

Immatics Announces Third Quarter 2024 Financial Results, Business Update and…

The Company will now target five major cancer types with its four clinically active compounds across both TCR-T cell therapies and TCR-based Bispecifics Today, Company discloses first clinical data from the TCR Bispecific molecule, TCER® IMA402 targeting PRAME, in the Phase 1 dose escalation trial, demonstrating a favorable tolerability profile and signs of dose-dependent and PRAME expression-dependent clinical activity, including first objective responses in melanoma patients; early...
Nasdaq GlobeNewswire
18/11/2024

MolecuLight® Applauds New CMS Local Coverage Determination (LCD) Changes for…

Key benefits of using MolecuLight® in conjunction with graft/skin substitute therapy: Key benefits of using MolecuLight® in conjunction with graft/skin substitute therapy: "We are committed to supporting healthcare providers in delivering optimal wound care," said Anil Amlani, CEO at MolecuLight. "Our technology empowers clinicians to make evidence-based decisions and improve patient outcomes. We are confident that MolecuLight will play a crucial role in meeting the new LCD…
PR Newswire
18/11/2024

Abbott Opens State-of-the-Art Global Manufacturing Facility in Kilkenny, Ireland

Speaking at the event, An Taoiseach, Simon Harris, TD, said, "Abbott, which has been in Ireland since 1946, is one of the longest-established global companies and largest employers in our country. This latest investment is a further vote of confidence in Ireland as a location for world-class advanced manufacturing and healthcare businesses. With the opening of this new site, Ireland is now at the global centre of diabetes care." Speaking at the event, An Taoiseach,Simon Harris, TD…
PR Newswire
18/11/2024

Ulike brings unmissable Black Friday deals to UK beauty lovers, featuring the…

With Ulike's patented Sapphire Ice Cooling technology, the Air 3 and Air 3 Deluxe keep the skin cool throughout treatment, making hair removal nearly painless, even on sensitive areas. The advanced IPL technology visibly reduces hair in as little as three weeks, achieving up to 93% reduction after four weeks by targeting hair at the root. The device also includes AutoGlide mode, enabling seamless, full-body treatments in just 13 minutes, along with three adjustable power modes to personalise the…
PR Newswire
18/11/2024

Zero Candida Applies to List its Shares on the TSX Venture Exchange

Immediately following the completion of the Acquisition, the following persons were appointed as directors of the Company: Immediately following the completion of the Acquisition, the following persons were appointed as directors of the Company: Eli Ben-HarooshAsher Holzer Orit Berger Christina Cameron Also, immediately following the completion of the Acquisition, the following persons were appointed as officers of the Company: Eli Ben-Haroosh, Chief Executive OfficerSophya...
PR Newswire
18/11/2024

EnteroBiotix Completes Phase 2 Study Recruitment of EBX-102-02 in Irritable…

EnteroBiotix Completes Phase 2 Study Recruitment of EBX-102-02 in Irritable Bowel Syndrome 122 patients with moderate to severe irritable bowel syndrome (IBS) were recruited to EnteroBiotix's Phase 2 TrIuMPH trial assessing EBX-102-02EnteroBiotix completed enrolment ahead of its planned schedule, dosing 62 participants with constipation predominant IBS (IBS-C) and 60 participants with diarrhoea predominant IBS (IBS-D)Topline data expected to readout in Q1 2025Glasgow, Scotland –...
Nasdaq GlobeNewswire
18/11/2024

Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through…

Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy Company founded by 4BIO Capital and Professor Steve Pollard as a spinout from the University of Edinburgh to commercialise its breakthrough Synthetic Super-Enhancer platform, Odysseus, to enable unprecedented precision in targeting aggressive cancersIQ Capital, Cancer Research Horizons, National Brain Tumor Society, AIN Ventures and Old College Capital now also investors in...
Nasdaq GlobeNewswire
18/11/2024

LIfT BioSciences expands into Ireland for manufacturing & clinical operations

LIfT BioSciences expands into Ireland for manufacturing & clinical operationsLondon,18 November 2024– LIfT BioSciences, ('LIfT' or 'the Company'), a rapidly emerging biotech company preparing to start clinical trials for its first-in-class allogeneic innate cell therapy, today announces the expansion of its manufacturing and clinical operations with the opening of a new subsidiary in Galway, Ireland,Eolaíocht Bhitheach LIfT Teoranta. This expansion marks a major milestone for...
Nasdaq GlobeNewswire
18/11/2024

Roche receives CE Mark for VENTANA FOLR1 (FOLR1-2.1) RxDx Assay as the first…

"This certification will allow us to extend the reach of our innovative diagnostic solutions," said Jill German, Head of Pathology Lab at Roche Diagnostics. "The early exemption approval in Germany and Austria highlighted the urgent need for this test. Now, clinicians across Europe can access a critical tool to quickly identify ovarian cancer patients who may be eligible for targeted therapy. By enabling more precise and personalised treatment decisions, we hope this may help…
PR Newswire
18/11/2024

NMD Pharma Initiates Phase 2 Study of NMD670 in Patients with…

NMD Pharma Initiates Phase 2 Study of NMD670 in Patients with Charcot-Marie-Tooth Disease Type 1 and 2Aarhus, Denmark, 18 November 2024– NMD Pharma A/S, a clinical-stage biotech company dedicated to developing novel and improved treatments for patients living with neuromuscular diseases, announces that it has dosed the first Charcot-Marie-Tooth (CMT) disease patient in its Phase 2a clinical trial of NMD670 followingFDA IND clearance in June 2024. The first patient was dosed under the...
Nasdaq GlobeNewswire
18/11/2024

Bylvay® (odevixibat) data shows sustained improvement in severe itch and serum…

Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024PARIS, FRANCE, 18 November, 2024Ipsen (Euronext: IPN; ADR: IPSEY) today announced data at the American Association for the Study of Liver Diseases (AASLD) assessing the long-term efficacy and safety of patients treated with Bylvay ®from two Phase III open-label extension studies: late-breaking abstract (#5045) on PEDFIC 2 in Progressive Familial...
Nasdaq GlobeNewswire
18/11/2024

Press Release: Sequana Medical Announces Strong 24-Month Results from POSEIDON…

Sequana Medical Announces Strong 24-Month Resultsfrom POSEIDON Study at AASLD The Liver Meeting® in San Diego;US PMA alfapump approval expected before end of Q1 2025 alfapump was very effective in control of ascites, virtually eliminating the need for large volume paracentesis (LVP) long term Key POSEIDON investigators report alfapump is safe and effective tool for patients requiring refractory ascites management for over six monthsOverall survival of 62% at two years in...
Nasdaq GlobeNewswire
18/11/2024

SoniVie Ltd., Appoints Veteran Medtech Executive Raymond W. Cohen as Chairman of…

Cohen is retiring from Axonics following the close of its $3.7 billion sale to Boston Scientific Corporation (NYSE: BSX). Cohen is retiring from Axonics following the close of its$3.7 billionsale to Boston Scientific Corporation (NYSE: BSX). Prior to Axonics, Cohen was the CEO of Vessix Vascular, Inc. (privately held) which developed a catheter based renal denervation system that was acquired by BSX in late 2012. Tomaso Zambelli, CEO of SoniVie, said "We look forward to benefiting...
PR Newswire
18/11/2024

KFSHRC Introduces Pioneering Virtual Pathology Services in Madinah

Reduces diagnostic turnaround times from a week to just one day RIYADH, Saudi Arabia, Nov.17, 2024(GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) has unveiled its state-of-the-art Virtual Pathology Service at the Madinah branch, revolutionizing the field of anatomical pathology through advanced digital technologies. This service dramatically enhances the speed, accuracy, and accessibility of diagnostics by eliminating the need for physical slide...
Nasdaq GlobeNewswire
17/11/2024

BMC Showcases Latest Sleep and Respiratory Healthcare Solutions at MEDICA 2024

Additionally, they introduced new product, the CoughSync device, which enables non-invasive clearance of airway secretions by simulating a natural cough in patients undergoing invasive ventilation. Additionally, they introduced new product, the CoughSync device, which enables non-invasive clearance of airway secretions by simulating a natural cough in patients undergoing invasive ventilation. During the exhibition, BMC's team assembled to highlight its innovative PAP Link Digital Health...
PR Newswire
16/11/2024

DermRays Black Friday Event Offers Year's Biggest Savings and Industry…

It's essential to clarify the long-term goals of laser hair removal. Technically, it is a process of "laser hair reduction" rather than complete "removal," as some hair regrowth is normal over time. Even with consistent treatments, new hair from dormant follicles may appear after one to three years. At-home laser devices offer a manageable, convenient skincare routine, giving lasting, visible results in a way that's easier, faster, and more affordable than traditional methods…
PR Newswire
16/11/2024

Junshi Biosciences Announces UK MHRA Approval for Marketing of Toripalimab

Toripalimab in combination with cisplatin and gemcitabine for the first-line treatment of adult patients with recurrent, not amenable to surgery or radiotherapy, or metastatic nasopharyngeal carcinoma (NPC);Toripalimab in combination with cisplatin and paclitaxel for the first-line treatment of adult patients with unresectable advanced, recurrent, or metastatic oesophageal squamous cell carcinoma (ESCC). In UK, toripalimab is the first and only drug for the treatment of NPC and the only...
Nasdaq GlobeNewswire
16/11/2024

d'Alba: Korea's Best-Kept Beauty Secret Set to Capture the Global Spotlight

While their domestic success is clear, d'Alba remains an under-the-radar name globally. Among those familiar with Korean beauty trends, d'Alba's white truffle-infused skincare is something of a well-kept secret, recognized by those closely attuned to K-beauty. With Korean consumers embracing the brand wholeheartedly, d'Alba is setting its sights on a new goal: making an international breakthrough. Wanting to bring the same excitement and exceptional skincare experience to beauty lovers…
PR Newswire
16/11/2024

Inventiva will present data from the final analysis of the Phase 2 study…

Data will be presented on Monday, November 18 thas a late breaker poster at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2024 in San Diego.LEGEND achieved its primary efficacy endpoint by significantly lowering HbA1c level in both the lanifibranor arm and in the lanifibranor with empagliflozin arm compared to placebo.50% percent of patients saw their HbA1c levels below 6.5% at week 24 following treatment with lanifibranor alone or in combination...
Nasdaq GlobeNewswire
15/11/2024

Global Hard Empty Capsule Market Forecast to Expand at a CAGR of 4.6% by 2030 -…

Claim Your Free Report: https://reports.valuates.com/request/sample/QYRE-Auto-29K7959/Global_and_China_Hard_Empty_Capsule_Market Claim Your Free Report: https://reports.valuates.com/request/sample/QYRE-Auto-29K7959/Global_and_China_Hard_Empty_Capsule_Market Major Factors Driving the Growth of Hard Empty Capsule Market: The hard empty capsule market is experiencing steady growth, driven by demand across pharmaceutical, nutraceutical, and healthcare sectors. Key factors include the...
PR Newswire
15/11/2024
Altri  Comunicati